These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 10333162)

  • 1. Possible use of amantadine in depression.
    Huber TJ; Dietrich DE; Emrich HM
    Pharmacopsychiatry; 1999 Mar; 32(2):47-55. PubMed ID: 10333162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amantadine revisited: an open trial of amantadinesulfate treatment in chronically depressed patients with Borna disease virus infection.
    Ferszt R; Kühl KP; Bode L; Severus EW; Winzer B; Berghöfer A; Beelitz G; Brodhun B; Müller-Oerlinghausen B; Ludwig H
    Pharmacopsychiatry; 1999 Jul; 32(4):142-7. PubMed ID: 10505484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dopaminergic agents, COMT inhibitors or amantadine? Proper treatment for your Parkinson patient].
    Ceballos-Baumann AO
    MMW Fortschr Med; 2002 May; Suppl 2():37-43. PubMed ID: 12070848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bupropion: a review of its mechanism of antidepressant activity.
    Ascher JA; Cole JO; Colin JN; Feighner JP; Ferris RM; Fibiger HC; Golden RN; Martin P; Potter WZ; Richelson E
    J Clin Psychiatry; 1995 Sep; 56(9):395-401. PubMed ID: 7665537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amantadine may reverse punding in Parkinson's disease--observation in a patient.
    Kashihara K; Imamura T
    Mov Disord; 2008 Jan; 23(1):129-30. PubMed ID: 17960816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine, depression and antidepressants.
    Dailly E; Chenu F; Renard CE; Bourin M
    Fundam Clin Pharmacol; 2004 Dec; 18(6):601-7. PubMed ID: 15548230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effect of imipramine and amantadine in the forced swimming test in rats. Behavioral and pharmacokinetic studies.
    Rogóz Z; Skuza G; Kuśmider M; Wójcikowski J; Kot M; Daniel WA
    Pol J Pharmacol; 2004; 56(2):179-85. PubMed ID: 15156068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential antidepressant effect of amantadine: a review of preclinical studies and clinical trials.
    Raupp-Barcaro IF; Vital MA; Galduróz JC; Andreatini R
    Braz J Psychiatry; 2018; 40(4):449-458. PubMed ID: 29898194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medications for Parkinson's disease.
    Whitney CM
    Neurologist; 2007 Nov; 13(6):387-8. PubMed ID: 18090719
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopaminergic-based pharmacotherapies for depression.
    Papakostas GI
    Eur Neuropsychopharmacol; 2006 Aug; 16(6):391-402. PubMed ID: 16413172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple rodent assay for the in vivo identification of agents with potential to reduce levodopa-induced dyskinesia in Parkinson's disease.
    Johnston TH; Lee J; Gomez-Ramirez J; Fox SH; Brotchie JM
    Exp Neurol; 2005 Feb; 191(2):243-50. PubMed ID: 15649479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty-five years of amantadine therapy in Parkinson's disease.
    Danielczyk W
    J Neural Transm Suppl; 1995; 46():399-405. PubMed ID: 8821075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amantadine in Parkinson's disease: pro and contra.
    Greulich W; Fenger E
    J Neural Transm Suppl; 1995; 46():415-21. PubMed ID: 8821077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic agents and stimulants as antidepressant augmentation strategies.
    Nierenberg AA; Dougherty D; Rosenbaum JF
    J Clin Psychiatry; 1998; 59 Suppl 5():60-3; discussion 64. PubMed ID: 9635549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Problematic long-term therapy of Parkinson's syndrome using amantadine salts].
    Diehl LW
    Med Welt; 1975 Nov; 26(48):2188-91. PubMed ID: 813085
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of joint administration of imipramine and amantadine in patients with drug-resistant unipolar depression.
    Rogóz Z; Dziedzicka-Wasylewska M; Daniel WA; Wójcikowski J; Dudek D; Wróbel A; Zieba A
    Pol J Pharmacol; 2004; 56(6):735-42. PubMed ID: 15662086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haloperidol-induced catalepsy: a model for screening antidepressants effective in treatment of depression with Parkinson's disease.
    Khisti RT; Mandhane SN; Chopde CT
    Indian J Exp Biol; 1997 Dec; 35(12):1297-301. PubMed ID: 9567763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The L-dopa sparing effect of G 31,406 in the treatment of parkinson's disease.
    Couto B; Oliveira C; Mattos JP; Freitas MR
    Neurol Neurocir Psiquiatr; 1976; 17(4):285-92. PubMed ID: 798128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of CREB in depression and antidepressant treatment.
    Blendy JA
    Biol Psychiatry; 2006 Jun; 59(12):1144-50. PubMed ID: 16457782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.